#Singapore #NICE Surgical #Purse-String Stapler #Trendlines Medical

NICE Surgical's Innovative Patent for a Purse-String Stapler

Introduction

On July 1, 2026, NICE Surgical Solutions Pte Ltd, a clinical-stage medical device firm based in Singapore, announced the awarding of U.S. Patent No. 12,653,527 B2 for its revolutionary purse-string stapler. This innovation stands to significantly enhance techniques in colorectal surgery by streamlining procedures that involve intracorporeal anastomosis. The company’s successful patent application highlights its commitment to advancing medical technology and improving surgical outcomes.

The Importance of the Purse-String Stapler

The patented device is designed to efficiently apply a purse-string suture around the tissue near an open lumen during colorectal surgery. This innovative approach enables a complete closure of the colon following surgery without the need for traditional abdominal incisions. As a result, surgeons can perform these operations minimally invasively, which could lead to fewer complications and a quicker recovery for patients.

In contrast to conventional methods that often involve making significant incisions, the purse-string stapler streamlines the surgical process and significantly reduces the risk of surgical site infections—one of the common concerns with standard surgical approaches.

Validation of Innovative Solutions

The granting of this patent not only validates NICE Surgical's cutting-edge technology but also underscores the potential benefits for patients undergoing colorectal procedures. By using innovative medical devices like the purse-string stapler, NICE Surgical aims to enhance surgical efficiency, reduce patient discomfort, and ultimately improve the quality of life following surgery.

Haim Brosh, CEO of Trendlines Medical Singapore Pte Ltd, NICE Surgical's parent company, expressed his enthusiasm regarding this achievement. He stated, “This patent is a testament to the dedication and ingenuity of the research and development team at NICE Surgical.” This milestone is a clear indication that NICE Surgical's mission of evolving surgical methods through technological advancements is progressive and impactful.

Path to Clinical Implementation

Looking forward, NICE Surgical is poised to progress into human clinical studies by Q4 2026, further evidencing the potential applications of their innovative medical solutions. Co-founder and inventor Eric Haas, MD, who also serves as the Chief of Colorectal Surgery at Houston Methodist Hospital, said, “Medical innovation transforms scientific discovery into better patient outcomes.” His enthusiasm reflects not only the anticipation surrounding the patent but also the expected improvements in surgical practices.

About Trendlines Group

NICE Surgical is backed by Trendlines Group Ltd, which is focused on investing in and developing advancements in medtech and agrifood technologies. With a robust operational presence in both Israel and Singapore, Trendlines seeks to translate early-stage innovations into businesses that deliver significant societal benefits and growth opportunities.

As the landscape of medical technology continues to evolve, NICE Surgical's commitment to innovative solutions encapsulates an optimistic future for surgical practices. With clinical trials on the horizon, the company is set to make a profound impact on how colorectal surgeries are performed, promising patients less invasive options and improved overall health outcomes.

Conclusion

NICE Surgical's purse-string stapler represents a significant leap forward in surgical innovation, encapsulating how advanced medical devices can reshape traditional surgical practices. As NICE Surgical prepares for the next steps in its journey toward making this technology widely available, the medical community watches closely, hopeful for positive changes in patient care through innovative approaches to surgery.